The agreement strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease ...

We recently compiled a list of the 10 Firms, Predominantly Gold Miners, Lead Wednesday Rally. In this article, we are going ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...

On Oct. 10, Boston Scientific sent an urgent medical device advisory to all affected customers with recommendations. Boston's device is used in ablation procedures to treat recurrent symptomatic ...

Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

The recall does not require doctors to stop using the catheters — existing inventory can be used with the new instructions, Boston Scientific said. Patients who have already had a procedure ...

Pulse Biosciences announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.

Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and ...

Boston Scientific said the Intracept procedure was expected to generate over $100 million in sales in 2024. Relievant also was one of the biggest customers of the University of North Texas ...

Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company's strategy to address coronary ...

The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted Accolade pacemakers, which may need to be replaced ...